[HTML][HTML] Oral antihyperglycemic therapy for type 2 diabetes mellitus

M de dépistage au Québec - CMAJ, 2005 - Can Med Assoc
Diet, regular exercise and weight loss are critical components of the treatment of diabetes
mellitus. However, orally administered antihyperglycemic agents (OHAs) are often …

Oral antihyperglycemic therapy for type 2 diabetes mellitus

AYY Cheng, IG Fantus - Cmaj, 2005 - Can Med Assoc
DIABETES MELLITUS IS A CHRONIC DISEASE that is growing in prevalence worldwide.
Pharmacologic therapy is often necessary to achieve optimal glycemic control in the …

Oral antihyperglycaemic agents in type 2 diabetes mellitus

H Smith - SA Pharmaceutical Journal, 2014 - journals.co.za
Diabetes mellitus is one of the most common chronic medical conditions worldwide, and
describes a group of metabolic disorders characterised by hyperglycaemia due to impaired …

What is the best oral hypoglycemic agents with insulin?

S Suh - International Congress of Diabetes and Metabolism, 2021 - kiss.kstudy.com
There have been significant advances in the understanding of glucose homeostasis and the
pathophysiology of type 2 diabetes mellitus (T2DM) over the past few decades. Impaired …

[HTML][HTML] Oral hypoglycemic agents for patients with type 2 diabetes mellitus

SH Ko - The Journal of Korean Diabetes, 2019 - synapse.koreamed.org
For patients with newly diagnosed type 2 diabetes mellitus (T2DM), lifestyle modifications
including medical nutrition therapy, weight control, physical activity, smoking cessation, and …

Therapeutic potential of α-glucosidase inhibitors in type 2 diabetes mellitus: an evidence-based review

SR Joshi, E Standl, N Tong, P Shah… - Expert opinion on …, 2015 - Taylor & Francis
Introduction: Postprandial hyperglycemia (PPHG) contributes to micro-and macro-vascular
complications more than fasting hyperglycemia in patients with type 2 diabetes mellitus. Due …

Considerations when using alpha-glucosidase inhibitors in the treatment of type 2 diabetes

MS Hedrington, SN Davis - Expert opinion on pharmacotherapy, 2019 - Taylor & Francis
ABSTRACT Introduction: Alpha-glucosidase inhibitors (AGIs)–oral antihyperglycemic drugs,
inhibit upper gastrointestinal enzymes that break down complex carbohydrates into glucose …

Clinical practice guidelines 2019 KDA: oral hypoglycemic agents in type 2 diabetes mellitus

고승현 - 대한당뇨병학회 학술발표논문집, 2019 - kiss.kstudy.com
처음 당뇨병을 진단받은 환자에게서는 우선 적극적인 생활습관개선을 하고, 이것만으로 A1C
목표에 도달하지 못한 경우에 약제치료를 시작한다. 약제치료는 경구혈당강하제 단독요법으로 …

Efficacy and tolerability of alpha-glucosidase inhibitors: a systematic review and meta-analysis of clinical trials

H Chen, V Saundankar… - Canadian …, 2009 - canadianjournalofdiabetes.com
Aims: The purpose of the study was to conduct a systematic literature review and meta-
analysis to compare the efficacy (glycemic control) and tolerability (hypoglycemia …

A model‐based meta‐analysis of 24 antihyperglycemic drugs for type 2 diabetes: comparison of treatment effects at therapeutic doses

A Maloney, J Rosenstock… - Clinical Pharmacology & …, 2019 - Wiley Online Library
Model‐based meta‐analysis was used to compare glycemic control, weight changes, and
hypoglycemia risk across 24 antihyperglycemic drugs used to treat type 2 diabetes …